Revolutionary tissue reconstruction tech secures €50M boost

TISSIUM, a cutting-edge medtech company specializing in biomorphic programmable polymers for tissue reconstruction, has successfully raised €50 million in a Series D funding round. The investment, supported by both new and returning international backers such as Fonds Stratégique des Transitions…

Will new investments in fusion power force a breakthrough?

Fusion power, a promising energy source that harnesses electricity from nuclear fusion reactions, has been gaining momentum recently due to notable breakthroughs and increased investments. This is exemplified by Microsoft’s recent power purchase agreement with fusion startup Helion Energy, which…